CGEM - CIK 0001789972
Cullinan Therapeutics, Inc. (CGEM) reported revenue of $0.00 for fiscal year 2022, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2022 | $0.00 | -100.0% |
| FY 2021 | $18.94M | - |
| FY 2020 | $0.00 | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.